{"id":487,"date":"2017-04-01T14:08:13","date_gmt":"2017-04-01T14:08:13","guid":{"rendered":"http:\/\/dsmuc1.de\/app\/?p=487"},"modified":"2019-12-13T09:05:49","modified_gmt":"2019-12-13T09:05:49","slug":"app-advises-consortium-on-stada-2","status":"publish","type":"post","link":"https:\/\/app-pharma.care\/?p=487","title":{"rendered":"APP advises consortium on Stada"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” admin_label=”Hero Section” _builder_version=”3.29.3″ global_module=”772″ saved_tabs=”all”][et_pb_fullwidth_header title=”News ” subhead=”read more” background_overlay_color=”rgba(0,0,0,0.61)” content_max_width=”550px” _builder_version=”3.29.3″ title_font=”Poppins|700||on|||||” title_text_color=”#edbb5f” title_font_size=”14px” title_letter_spacing=”2px” title_line_height=”1.4em” content_font=”Poppins||||||||” content_font_size=”16px” content_letter_spacing=”1px” content_line_height=”2em” subhead_font=”Playfair Display|700||on|||||” subhead_font_size=”48px” subhead_letter_spacing=”3px” subhead_line_height=”1.4em” background_color=”rgba(255, 255, 255, 0)” background_image=”http:\/\/app-pharma.care\/wp-content\/uploads\/2019\/09\/cellphone-coffee-desk-860379.jpg” parallax=”on” parallax_method=”on” custom_button_one=”on” button_one_border_width=”1px” button_one_border_color=”rgba(255,255,255,0.3)” button_one_border_radius=”0px” button_one_letter_spacing=”1px” button_one_font=”Saira Extra Condensed|600||on|||||” button_one_icon=”%%3%%” button_one_icon_color=”#edbb5f” custom_button_two=”on” button_two_border_width=”1px” button_two_border_color=”rgba(255,255,255,0.3)” button_two_border_radius=”0px” button_two_letter_spacing=”1px” button_two_font=”Saira Extra Condensed|600||on|||||” button_two_icon=”%%3%%” button_two_icon_color=”#edbb5f” module_alignment=”right” min_height=”317px” custom_margin=”|||” custom_padding=”4%||5%|||” button_one_text_color_hover=”#edbb5f” button_two_text_color_hover=”#edbb5f” button_one_bg_color_hover=”rgba(0,0,0,0)” button_two_bg_color_hover=”rgba(0,0,0,0)” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_one_text_color__hover_enabled=”on” button_one_text_color__hover=”#edbb5f” button_two_text_color__hover_enabled=”on” button_two_text_color__hover=”#edbb5f” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_one_bg_color__hover_enabled=”on” button_one_bg_color__hover=”rgba(0,0,0,0)” button_two_bg_color__hover_enabled=”on” button_two_bg_color__hover=”rgba(0,0,0,0)”]<\/p>\n

 <\/p>\n

 <\/p>\n

[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”news” _builder_version=”3.27.4″ custom_margin=”|||” custom_padding=”100px|0px|19px|0px||”][et_pb_row use_custom_gutter=”on” gutter_width=”4″ _builder_version=”3.25″ animation_style=”fade”][et_pb_column type=”4_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_post_title _builder_version=”3.27.4″ title_font=”Playfair Display|700|||||||” title_font_size=”32px” meta_font=”Poppins||||||||”][\/et_pb_post_title][et_pb_divider color=”#edbb5f” divider_weight=”2px” _builder_version=”3.2″ max_width=”60px” module_alignment=”left” height=”2px” global_module=”350″ saved_tabs=”all”][\/et_pb_divider][et_pb_text _builder_version=”3.27.4″ text_font=”Poppins||||||||” text_font_size=”16px” min_height=”44px”]<\/p>\n

\n
\n
\n
\n

Funds advised by Bain Capital Private Equity, LP (\u201cBain Capital\u201d) and by Cinven Partners LLP (\u201cCinven\u201d), announced the intention to launch a voluntary public takeover offer (the \u201cTakeover Offer\u201d) for all outstanding shares of STADA Arzneimittel AG (\u201cSTADA\u201d or the \u201cCompany\u201d).<\/p>\n

STADA is a leading, independent pharmaceutical company listed on the Frankfurt Stock Exchange. The Company offers a comprehensive portfolio of high-quality, low-cost generic products including selected biosimilars. STADA has also built an attractive portfolio of well-established branded products, including the cold medicine Grippostad\u00ae and the Ladival\u00ae range of sun protection products.<\/p>\n

APP conducted the commercial and product due diligence and advised on all industry aspects of the transaction.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

[\/et_pb_text][et_pb_divider color=”#edbb5f” divider_weight=”2px” _builder_version=”3.2″ max_width=”60px” module_alignment=”left” height=”2px” global_module=”350″][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Contact” _builder_version=”3.27.4″ custom_padding=”2px|0px|18px|0px||” animation_style=”zoom” global_module=”339″ saved_tabs=”all”][et_pb_row column_structure=”1_4,1_2,1_4″ _builder_version=”3.27.4″ max_width=”1440px” animation_style=”slide” animation_duration=”1500ms”][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][et_pb_text module_id=”contact” _builder_version=”3.27.4″ text_font=”Work Sans|600|||||||” text_line_height=”2em” header_font=”||||||||” header_2_font=”Suranna|||on|||||” header_2_font_size=”3vw” header_2_line_height=”1.2em” header_3_font=”Raleway|700||on|||||” header_3_font_size=”12px” header_3_letter_spacing=”1.5px” header_3_line_height=”2em” header_4_font=”||||||||” header_2_font_size_tablet=”5vw” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” border_color_all=”#f3f1f2″ locked=”off”]<\/p>\n

contact us<\/h2>\n

[\/et_pb_text][et_pb_text content_tablet=”” content_phone=”” content_last_edited=”on|desktop” module_id=”contact” _builder_version=”3.27.4″ text_font=”Poppins||||||||” text_font_size=”16px” text_line_height=”1em” header_font=”Poppins||||||||” header_2_font=”Suranna|||on|||||” header_2_font_size=”3vw” header_2_line_height=”1.2em” header_3_font=”Raleway|700||on|||||” header_3_font_size=”12px” header_3_letter_spacing=”1.5px” header_3_line_height=”2em” header_4_font=”||||||||” header_2_font_size_tablet=”5vw” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” border_color_all=”#f3f1f2″ locked=”off”]<\/p>\n

Albrecht, Prock & Partners AG<\/p>\n

B\u00f6dlistrasse 3c<\/p>\n

CH-6314 Unteraegeri – Zug, Switzerland<\/p>\n

office(at)ca-pp.net<\/p>\n

[\/et_pb_text][et_pb_contact_form email=”office@ca-pp.net” _builder_version=”3.27.2″ custom_button=”on” button_text_color=”#a0a0a0″ border_color_all=”#000000″][et_pb_contact_field field_id=”Name” field_title=”Name” _builder_version=”3.16″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Email” field_title=”Email Address” field_type=”email” _builder_version=”3.16″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Message” field_title=”Message” field_type=”text” fullwidth_field=”on” _builder_version=”3.16″ button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”3.25″ custom_padding=”|||” custom_padding__hover=”|||”][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

    Funds advised by Bain Capital Private Equity, LP (\u201cBain Capital\u201d) and by Cinven Partners LLP (\u201cCinven\u201d), announced the intention to launch a voluntary public takeover offer (the \u201cTakeover Offer\u201d) for all outstanding shares of STADA Arzneimittel AG (\u201cSTADA\u201d or the \u201cCompany\u201d). STADA is a leading, independent pharmaceutical company listed on the Frankfurt Stock […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/487"}],"collection":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=487"}],"version-history":[{"count":5,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/487\/revisions"}],"predecessor-version":[{"id":913,"href":"https:\/\/app-pharma.care\/index.php?rest_route=\/wp\/v2\/posts\/487\/revisions\/913"}],"wp:attachment":[{"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-pharma.care\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}